Latest filing published 22 Apr 2026 for 한화생명, €15k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +7.4%Entry ₩4,850 · Close 08 Oct 2026 ₩5,210
- +5.6%Entry ₩2,970 · Close at T+365 ₩3,135
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
김준일: trading record in brief
All filings by 김준일 on record concern 한화생명, in the capacity of chief executive. Between 7 August 2024 and 22 April 2026, the trades on record add up to 2 filings.
No open-market sale appears; the market trades are 2 purchases worth €15k. No amount is published for 1 filing, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2026 to date brings 1 purchase and no sales.
Most recently, on 22 April 2026, the filings show an open-market purchase worth €15k in 한화생명. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to 김준일
Open company profiles for insider transactions, fundamentals and analyst consensus when available.